Medicare Enrolled

Dr. Cyrus Parsa, M.D.

Thoracic Surgery · Rome, GA
Practice pattern: Cardiac & Interventional — Practice combining cardiac and interventional services
100 JOHN MADDOX DR NW STE 100, Rome, GA 30165
7065289060
Registered in NPPES since 2008
NPI: 1235396110 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Parsa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parsa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Parsa

Dr. Cyrus Parsa is a thoracic surgery specialist in Rome, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Parsa performed 332 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Parsa received a total of $3,477 from 19 pharmaceutical and/or device companies across 147 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Parsa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 28% volume in GA $3,477 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
332
Medicare services
Top 28% in GA for thoracic surgery
Not available
Unique patients (not deduplicated)
$217
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Transcatheter aortic valve replacement via femoral artery
A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery.
50 $579 $3,768
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
45 $64 $269
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
40 $132 $525
New patient office visit, complex (60-74 min) 39 $164 $660
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
38 $40 $152
Coronary artery bypass graft, 1 artery
Surgical procedure to bypass a blocked coronary artery using a graft from another artery. This restores blood flow to the heart muscle.
34 $641 $2,671
Endoscopic vein harvest
A surgical procedure to remove a vein using an endoscope, which is a thin, lighted tube inserted through small incisions.
33 $6 $24
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
30 $58 $240
Coronary artery bypass graft, 2 grafts
A surgical procedure to restore blood flow to the heart by creating bypasses using two vein or artery grafts.
23 $143 $583
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
32.2% high complexity
0.0% medium
67.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,477
Total received (2018-2024)
Avg $497/year across 7 years
Bottom 47% in GA for thoracic surgery
19
Companies
147
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$802
2023
$648
2022
$360
2021
$438
2020
$384
2019
$346
2018
$500

Payments by company (2024)

Edwards Lifesciences Corporation
$434
ATRICURE, INC.
$265
Becton, Dickinson and Company
$49
LSI SOLUTIONS INC
$29
Getinge USA Sales, LLC
$24
Top 3 companies account for 93.4% of 2024 payments
All-time payments by company (2018-2024) ›
Edwards Lifesciences Corporation
$1,943
ATRICURE, INC.
$282
ABIOMED
$173
Artivion, Inc.
$130
AtriCure, Inc.
$125
LivaNova USA, Inc.
$122
Boston Scientific Corporation
$106
Medtronic, Inc.
$98
Abbott Laboratories
$98
LSI SOLUTIONS INC
$78
Getinge USA Sales, LLC
$66
AngioDynamics, Inc.
$63
Medtronic Vascular, Inc.
$60
Becton, Dickinson and Company
$49
Potrero Medical, Inc.
$26
Varian Medical Systems, Inc.
$16
Esperion Therapeutics, Inc.
$15
DAVOL INC.
$15
EKOS Corporation
$14
Top 3 companies account for 68.9% of all-time payments
Associated products mentioned in payments ›
3F · ANGIOVAC · ARISTA AH FlexiTip · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE ATRICLIP LAA EXCLUSION · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · AngioVac · Aortic and Mitral Tissue Stented Valves · BIOGLUE SURGICAL ADHESIVE · CARDIOSAVE HYBRID · COR KNOT · COR-KNOT · CoreValve Evolut · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EKOSONIC · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Epi-Sense Guided Coagulation System with VisiTrax · Epic Stented Tissue Valve · GENERAL THERAPIES · INSPIRIS RESILIA AORTIC VALVE · Impella · LOTUS EDGE · Models · NEXLETOL · ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER · PROGEL · Perceval · SAPIEN 3 Ultra RESILIA · SYNERGY ABLATION SYSTEM · TYPE B PLUG · Trifecta GT Tissue Heart Valve · TrueBeam · Vasoview Hemopro 2
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a thoracic surgery specialist in Rome?
Compare thoracic surgerists in the Rome area by procedure volume, costs, and industry payment transparency.
Browse thoracic surgerists nearby

Geographic Context

Thoracic surgerists in nearby ZIP areas
6
County median income
$62,540
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH REDMOND
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Parsa is a cardiac & interventional specialist, with above-average Medicare volume (top 28% in GA), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Parsa experienced with transcatheter aortic valve replacement via femoral artery?
Based on Medicare claims data, Dr. Parsa performed 50 transcatheter aortic valve replacement via femoral artery services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Parsa receive payments from pharmaceutical companies?
Yes. Dr. Parsa received a total of $3,477 from 19 companies across 147 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parsa's costs compare to other thoracic surgerists in Rome?
Dr. Parsa's average Medicare payment per service is $217. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parsa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →